The Manufacturers Life Insurance Company trimmed its stake in shares of Livent Co. (NYSE:LTHM – Get Rating) by 0.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 64,865 shares of the company's stock after selling 473 shares during the quarter. The Manufacturers Life Insurance Company's holdings in Livent were worth $1,988,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently made changes to their positions in the business. Crossmark Global Holdings Inc. grew its stake in shares of Livent by 2.5% in the 3rd quarter. Crossmark Global Holdings Inc. now owns 14,975 shares of the company's stock worth $459,000 after purchasing an additional 360 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Livent by 0.4% in the 2nd quarter. Nisa Investment Advisors LLC now owns 114,851 shares of the company's stock worth $2,606,000 after purchasing an additional 479 shares during the last quarter. Great West Life Assurance Co. Can grew its stake in shares of Livent by 0.4% in the 1st quarter. Great West Life Assurance Co. Can now owns 139,532 shares of the company's stock worth $3,734,000 after purchasing an additional 529 shares during the last quarter. Regent Investment Management LLC grew its stake in shares of Livent by 1.1% in the 3rd quarter. Regent Investment Management LLC now owns 57,525 shares of the company's stock worth $1,763,000 after purchasing an additional 600 shares during the last quarter. Finally, Maryland State Retirement & Pension System grew its stake in shares of Livent by 1.2% in the 2nd quarter. Maryland State Retirement & Pension System now owns 65,542 shares of the company's stock worth $1,487,000 after purchasing an additional 750 shares during the last quarter. Institutional investors and hedge funds own 90.62% of the company's stock.
Get Livent alerts:Livent Price Performance
NYSE LTHM opened at $25.97 on Friday. The company has a quick ratio of 2.65, a current ratio of 3.52 and a debt-to-equity ratio of 0.18. The stock has a market capitalization of $4.66 billion, a PE ratio of 25.97 and a beta of 1.82. The company has a 50 day moving average price of $23.38 and a two-hundred day moving average price of $27.45. Livent Co. has a 12-month low of $18.26 and a 12-month high of $36.38.
Livent (NYSE:LTHM – Get Rating) last posted its earnings results on Tuesday, November 1st. The company reported $0.41 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.41. The firm had revenue of $231.60 million during the quarter, compared to analysts' expectations of $248.19 million. Livent had a net margin of 27.67% and a return on equity of 20.00%. As a group, equities analysts predict that Livent Co. will post 1.35 earnings per share for the current fiscal year.Analyst Ratings Changes
Several research firms have recently weighed in on LTHM. Mizuho dropped their target price on shares of Livent from $31.00 to $27.00 and set a "neutral" rating on the stock in a research report on Thursday, January 12th. JPMorgan Chase & Co. began coverage on shares of Livent in a research report on Monday, October 17th. They issued a "neutral" rating and a $28.00 target price on the stock. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Livent from $30.00 to $22.00 in a research report on Tuesday, January 10th. Piper Sandler dropped their target price on shares of Livent from $42.00 to $38.00 and set an "overweight" rating on the stock in a research report on Thursday, December 15th. Finally, B. Riley boosted their price objective on shares of Livent from $30.00 to $32.00 and gave the company a "neutral" rating in a research report on Thursday, October 27th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, Livent currently has a consensus rating of "Moderate Buy" and an average price target of $28.78.
About Livent
(Get Rating)
Livent Corp. engages in the production of performance lithium compounds. Its products include battery-grade lithium hydroxide, butyllithium, and purity lithium metal which are used in various performance applications. It operates through the following geographical segments: North America, Europe, Middle East, and Africa, Latin America, and Asia Pacific.
See Also
- Get a free copy of the StockNews.com research report on Livent (LTHM)
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- Ford Stock Going Forward After Big Earnings Flop
- Insiders And Institutions Buy Wolverine Worldwide
Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.